Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: A 6-month, randomized, double-blind trial

Journal of Hypertension

Volumn 26, Issue 3, 2008, Pages 589-592

  Andersen, Karl ^a   Weinberger, Myron H ^b   Egan, Brent ^c   Constance, Christian M ^d   Ali, Mohammed A ^e   Jin, James ^e   Keefe, Deborah L ^e  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^e NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Aliskiren; Angiotensin converting enzyme inhibitor; Antihypertensive therapy; Direct renin inhibitor; Diuretic; Ramipril

Indexed keywords

ALISKIREN; HYDROCHLOROTHIAZIDE; PLACEBO; RAMIPRIL;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; BACKACHE; BLOOD PRESSURE REGULATION; BRONCHITIS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CREATININE BLOOD LEVEL; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPERTENSION; INFLUENZA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NAUSEA; PAIN; PERIPHERAL EDEMA; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SIDE EFFECT; SINUSITIS; SYSTOLIC BLOOD PRESSURE; UPPER RESPIRATORY TRACT INFECTION; UREA NITROGEN BLOOD LEVEL;

EID: 39849089447     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3282f3ad9a     Document Type: Article

References (32)